The Impact of Syndromic Genetic Disorders on Medical Management and Mortality in Pediatric Hypertrophic Cardiomyopathy P
- PDF / 730,720 Bytes
- 10 Pages / 595.276 x 790.866 pts Page_size
- 35 Downloads / 161 Views
ORIGINAL ARTICLE
The Impact of Syndromic Genetic Disorders on Medical Management and Mortality in Pediatric Hypertrophic Cardiomyopathy Patients Jonathan B. Edelson1 · Heather Griffis2 · Danielle S. Burstein1 · Xuemei Zhang2 · Joseph W. Rossano1 · Kimberly Y. Lin1 · Matthew J. O’Connor1 Received: 13 February 2020 / Accepted: 21 May 2020 © Springer Science+Business Media, LLC, part of Springer Nature 2020
Abstract Hypertrophic cardiomyopathy (HCM) is a prevalent cardiomyopathy in children, with variable etiologies, phenotypes, and associated syndromic genetic disorders (GD). The spectrum of evaluation in this heterogeneous population has not been well described. We aimed to describe mortality and medical management in the pediatric HCM population, and compare HCM pediatric patients with GD to those without GD. Children (
Data Loading...
